SGMO - Sangamo Therapeutics Inc. (SGMO) CEO Sandy Macrae on Q1 2022 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (SGMO) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief Executive Officer Rob Schott - Head of Development Jason Fontenot - Chief Scientific Officer Prathyusha Duraibabu - Chief Financial Officer Bettina Cockroft - Chief Medical Officer Conference Call Participants Yanan Zhu - Wells Fargo Nicole Germino - Truist Securities Luca Issi - RBC Capital Kelly O'Brien - Stifel Gregory Harrison - Bank of America Kevin Estok - Jefferies Ritu Baral - Cowen Patrick Trucchio - HC Wainwright Presentation Operator Thank you for standing by, and welcome to Sangamo First Quarter 2022 Teleconference Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Louise Wilkie. Thank you. Please go ahead. Louise Wilkie Good afternoon, and thank you for

For further details see:

Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2022 Results - Earnings Call Transcript